ONENESS BIOTECH CO., LTD.
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2008-06-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.onenessbio.com.tw
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
- Conditions
- Allergic Asthma
- Interventions
- Biological: FB825Other: Placebo
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT05008965
- Locations
- 🇨🇳
Kaohsiung Chang Gung Medical Foundation, Kaohsiung, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei city, Taiwan
🇨🇳China Medical University Hospital, Taichung City, Taiwan
Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
- Conditions
- Chronic Diabetic Foot Ulcers
- Interventions
- Other: Vehicle Cream
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04962139
- Locations
- 🇺🇸
Oneness Investigational Site, McAllen, Texas, United States
A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT04945161
- Locations
- 🇨🇳
Kueiho Chen, Taipei, Taiwan
Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Biological: FB825Other: Placebo
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT04413942
- Locations
- 🇺🇸
FXM Clinical Research Ft. Lauderdale, LLC., Fort Lauderdale, Florida, United States
🇺🇸Encino Research Center, Encino, California, United States
🇺🇸Zenith Research, Beverly Hills, California, United States
The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT02353273
- Locations
- 🇨🇳
Clinical Research Division, Taipei, Taiwan
Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
- Conditions
- Advanced Solid Malignancies
- Interventions
- Drug: OB318 capsule
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02347228
- Locations
- 🇨🇳
Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
- Conditions
- Diabetic Foot
- Interventions
- Other: Aquacel® Hydrofiber® dressing
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 236
- Registration Number
- NCT01898923
- Locations
- 🇨🇳
Chi Mei Medical Center-Yongkang, Tainan City, Taiwan
🇨🇳Chang Gung Medical Hospital_Linkou, Taoyuan City, Taiwan
🇨🇳China Medical University Hospital-Beigang Branch, Yunlin, Taiwan
Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
- Conditions
- Chronic Diabetic Foot Ulcer
- Interventions
- Drug: DCB-WH1 ointmentDrug: Placebo
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Oneness Biotech Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT00709514
- Locations
- 🇨🇳
Clinical Research Division, Taipei, Taiwan